Psychiatric implications of anti-seizure medications in epileptic population

被引:1
|
作者
Khalid, Bushra [1 ]
Waqar, Zaid [1 ]
Khan, Soban [1 ]
Ali, Ijaz [1 ]
Afzal, Naheed [1 ]
Irfan, Anum [1 ]
Malik, Waleed [1 ]
Adil, Malik Muhammad [1 ]
Saddiqa, Amina [1 ]
Khalil, Maryam [1 ]
Munawar, Zeeshan [1 ]
机构
[1] Pakistan Inst Med Sci, Islamabad, Pakistan
关键词
Epilepsy; Antiseizure medications; Psychiatric comorbidities; Valproate; MRI findings; DEPRESSION; CLASSIFICATION; COMORBIDITIES; DEFINITION; ILAE;
D O I
10.1186/s12883-024-03670-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and objective Epilepsy is a prevalent neurological disorder that affects a significant number of individuals globally. This condition is associated with a high occurrence of psychiatric comorbidities, which can significantly affect the quality of life of individuals affected. The aim of this study was to investigate the association between antiseizure therapies and the likelihood of psychiatric comorbidities in individuals with epilepsy.Methodology Data for this study was gathered from the Neurology referral center in Islamabad, Pakistan. A standardized questionnaire was utilized to gather data from 120 individuals diagnosed with epilepsy. The survey consisted of inquiries regarding the management of seizures, the utilization of anti-seizure medications, and the presence of psychiatric comorbidities. The data was analyzed using the Statistical Package for the Social Sciences (SPSS).Results The findings indicated that individuals who were using multiple antiseizure medications had a notably higher likelihood of having psychiatric comorbidities in comparison to those who were on mono therapy (p = 0.010). suggests that patients with unsuccessful seizure control are more probable to have psychiatric comorbidities as compared to those with good seizure control (p = 0.029).Conclusion To conclude poor seizure control and poly therapy are associated with increased risk of psychiatric comorbidities.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] How cenobamate influences plasmatic concentration of concomitant anti-seizure medications
    Fernandes, C.
    Cunha, I.
    Bras, A.
    Silva, Ai
    Teotonio, R.
    Bento, C.
    Sales, F.
    EPILEPSIA, 2024, 65 : 194 - 194
  • [42] What are the predominant predictors of seizure relapse following discontinuation of anti-seizure medication in epileptic children?
    Kanmaz, Seda
    Toprak, Dilara Ece
    Olculu, Cemile Busra
    Dokurel, Ipek
    Simsek, Erdem
    Serin, Hepsen Mine
    Yilmaz, Sanem
    Aktan, Gul
    Gokben, Sarenur
    Tekgul, Hasan
    EPILEPTIC DISORDERS, 2023, 25 (02) : 218 - 228
  • [43] Which psychogenic nonepileptic seizure (PNES) patients are more likely to be treated with anti-seizure medications?
    Spierer, Ronen
    Herskovitz, Moshe
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2024, 117 : 111 - 114
  • [44] Quality of life in people with epilepsy: The associations of anti-seizure medications and biopsychosocial variables
    Thomas, Julia A.
    Ditchman, Nicole M.
    Breting, Leslie Guidotti
    Narayanan, Jaishree
    EPILEPSY & BEHAVIOR, 2024, 152
  • [45] Effect of anti-seizure medications and other neuromodulating drugs on ductus arteriosus contractility
    Eschrich, J. W.
    Sekulich, D.
    Charron, E. M.
    Boatwright, N.
    Brown, A.
    Pagano, L.
    Alrifai, W.
    Reese, J.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369
  • [46] Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy
    Fujimoto, Ayataka
    Enoki, Hideo
    Hatano, Keisuke
    Sato, Keishiro
    Okanishi, Tohru
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [47] RACIAL AND ETHNIC DISPARITIES IN ADHERENCE TO ANTI-SEIZURE MEDICATIONS AMONG PATIENTS WITH EPILEPSY
    Jian, Y.
    Borhade, A.
    Choi, L.
    Lee, B.
    Lee, G.
    Shabbak, R.
    Wategaonkar, A.
    Afghani, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 109 - 111
  • [48] Priapism associated with anti-seizure medications: a pharmacovigilance study and a review of published cases
    Petrovic, Nemanja Z.
    Pejcic, Ana V.
    Milovanovic, Ivan R.
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (01) : 67 - 78
  • [49] Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications
    Bermeo-Ovalle, Adriana
    EPILEPSY CURRENTS, 2019, 19 (02) : 96 - 98
  • [50] Ketosis and anti-seizure medications: Shared mechanisms of action in bipolar disorder and epilepsy
    Campbell, Iain
    BIPOLAR DISORDERS, 2024, 26 : 149 - 150